Targeting Müller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity.
about
The role of Toll-like receptors in retinal ischemic diseasesGenomics in the neonatal nursery: Focus on ROP.Vascular endothelial growth factor antagonist therapy for retinopathy of prematurityRole of VEGF Inhibition in the Treatment of Retinopathy of Prematurity.Retinal Inhibition of CCR3 Induces Retinal Cell Death in a Murine Model of Choroidal NeovascularizationMüller Glia Are a Major Cellular Source of Survival Signals for Retinal Neurons in Diabetes.Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization.Advances in diagnosis, clinical care, research, and treatment in retinopathy of prematurity.Pathophysiology and mechanisms of severe retinopathy of prematurity.Advances in understanding and management of retinopathy of prematurity.Effect of subretinal injection on retinal structure and function in a rat oxygen-induced retinopathy model.Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Müller cells maintains retinal function by triggering different signaling mechanisms.VEGF production and signaling in Müller glia are critical to modulating vascular function and neuronal integrity in diabetic retinopathy and hypoxic retinal vascular diseases.The Free Radical Diseases of Prematurity: From Cellular Mechanisms to Bedside
P2860
Q28072125-7251574D-5229-498B-BB96-6F2759CA168AQ34498407-95F877C7-1E53-473B-8C19-FBAE5D1700F7Q35473907-4333FA3A-7E94-4750-A9FA-A5994A535733Q35950878-C512FCAB-E397-4CD3-B4CD-AF01A74D9A9AQ36053934-9D94C519-A81C-4AA2-B79A-375602CF6D3DQ36104659-8DA316F7-BF75-433A-A679-E58AEF6EA896Q36126070-4DB69F95-1563-4E5D-85FC-F3767E67D275Q37370267-69E00198-0853-4AE3-96D1-F783B3E47D90Q38274655-F2FAE844-8D16-4169-876E-107F3F15BCABQ39052915-16245292-F2C5-49D8-91FA-32C2016C83E2Q47113822-07C821E0-CD82-482E-BEE4-00E040F63CBBQ47828029-DA27F0BB-AB8F-4B93-962D-5C2D10A36922Q48768631-DE048C98-6E59-4F5C-AF23-61EBA409B30FQ58188912-62FBB506-F2DA-4FF8-9139-4573B5073777
P2860
Targeting Müller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting Müller cell-derived ...... of retinopathy of prematurity.
@en
Targeting Müller cell-derived ...... of retinopathy of prematurity.
@nl
type
label
Targeting Müller cell-derived ...... of retinopathy of prematurity.
@en
Targeting Müller cell-derived ...... of retinopathy of prematurity.
@nl
prefLabel
Targeting Müller cell-derived ...... of retinopathy of prematurity.
@en
Targeting Müller cell-derived ...... of retinopathy of prematurity.
@nl
P2093
P2860
P356
P1476
Targeting Müller cell-derived ...... of retinopathy of prematurity.
@en
P2093
David Culp
Haibo Wang
Lori Fotheringham
M Elizabeth Hartnett
Scott Hammond
Yanchao Jiang
Zhihong Yang
P2860
P304
P356
10.1167/IOVS.13-13755
P407
P577
2014-02-10T00:00:00Z